BRAF NP_004324.2:P.V600E

Clinical trials for BRAF NP_004324.2:P.V600E explained in plain language.

Never miss a new study

Get alerted when new BRAF NP_004324.2:P.V600E trials appear

Sign up with your email to follow new studies for BRAF NP_004324.2:P.V600E, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

First trial launches to attack deadly thyroid cancer with drug and radiation double punch

Disease control Recruiting now

This early-stage trial is testing a new combination treatment for a rare and very aggressive form of thyroid cancer. It combines two targeted drugs (dabrafenib and trametinib) with a precise form of radiation therapy. The main goal is to find the safest dose of this combination a…

Matched conditions: BRAF NP_004324.2:P.V600E

Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

BRAF NP_004324.2:P.V600E

Get alerted when new BRAF NP_004324.2:P.V600E trials appear

First trial launches to attack deadly thyroid cancer with drug and radiation double punch